Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

被引：0
|
作者：
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
机构：
[1] Baskent University Faculty of Medicine,Department of Pediatrics, Pediatric Hematology Unit
[2] Baskent University Faculty of Medicine,Department of Cardiovascular Surgery
来源：
Pediatric Cardiology | 2005年 / 26卷
关键词：
Recombinant factor VIIa; Cardiopulmonary bypass; Cardiac surgery; Glanzmann thrombasthenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
引用
收藏
页码：843 / 845
页数：2
相关论文
共 50 条
  • [21] Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery
    Chapman, Alistair J.
    Blount, Andrew L.
    Davis, Alan T.
    Hooker, Robert L.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (06) : 1314 - 1319
  • [22] Successful IVF and pregnancy in Glanzmann's thrombasthenia under cover of recombinant factor VIIa
    Staritz, P.
    Zimmermann, R.
    Domschke, C.
    Strowitzki, T.
    Sohn, C.
    Huth-Kuehne, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1153 - 1154
  • [23] USE OF RECOMBINANT FACTOR VIIA (RVIIA) IN GLANZMANN THROMBASTHENIA: A SYSTEMATIC REVIEW OF THE LITERATURE
    Samelson-Jones, Ben J.
    Lambert, Michele P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E22 - E22
  • [24] CASE REPORT: Successful Surgery Using Recombinant Factor VIIa for Recurrent, Idiopathic Nonulcer Duodenal Bleeding in a Patient with Glanzmann's Thrombasthenia
    Henk R. van Buuren
    Jenne J. Wielenga
    Digestive Diseases and Sciences, 2002, 47 : 2134 - 2136
  • [25] Successful epistaxis axis control in a patient with glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa
    Chuansumrit, A
    Sangkapreecha, C
    Hathirat, P
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1778 - 1778
  • [26] Pregnancy and Delivery Management With Recombinant Factor VIIa in a Glanzmann Thrombasthenia Patient: A Case Report
    Enciso, Leonardo
    Aragon-Mendoza, Rafael L.
    Leon, Laura A.
    Torres-Torres, Carrie G.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [27] Therapeutic use of recombinant human factor VIIa (rhFVIIa) in the management of glanzmann thrombasthenia.
    Kim, J
    Basani, R
    Friedman, D
    Poncz, M
    BLOOD, 1999, 94 (10) : 81B - 81B
  • [28] Successful use of rFVIIa (NovoSeven) and fibrin sealant (Tisseal) during dental work and tooth extraction in a pediatric patient with Glanzmann's thrombasthenia.
    Mathew, P
    Beetstra, SM
    Tatlock, CD
    Ventre, KM
    Jones, JE
    Schwartz, M
    Halona-Trujillo, MA
    Winter, S
    BLOOD, 2000, 96 (11) : 67B - 67B
  • [29] The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath®
    Ancliff, P
    Liesner, R
    Khair, K
    Hann, I
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (07) : 447 - 448
  • [30] Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia
    Ismael, F.
    van der Meer, J.
    de Wolf, J. Th. M.
    Kuizenga, K.
    Aarts, L. P. H. J.
    Hendriks, H. G. D.
    ANESTHESIA AND ANALGESIA, 2006, 103 (03): : 791 - 792
12345